Article
Defining Type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
2020-07-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background </bold>Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Elevated biomarker levels, such as eosinophils (EOS), fraction of exhaled nitric oxide (FeNO) and immunoglobulin E (IgE), are key clinical indicators of Type 2 i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6b824415-b5af-5501-9ffd-86b010508991
- DOI
- 10.21203/rs.3.rs-44856/v1
